Angiotech (ANPI)

Company

ANPI 1-year chart ANPI 1-year chart

"Angiotech is a global specialty pharmaceutical and medical device company that discovers, develops, and markets innovative technologies and medical products primarily for local diseases or for complications associated with medical device implants, surgical interventions and acute injury." (company website)

ANPI 6-month chart
ANPI 6-month chart

Buy

Until April 2006, Antiotech was on a steep down slope, but it has since been rising steadily. It got a huge boost from blowing past Expectations when earnings were reported in May. For the past two months ANPI has been consolidating below $7.

  • Price momentum (PPO) — dramatic increase since bottom, although slowed somewhat during consolidation
  • Relative strength (RSI) — strengthened greatly since bottom, pulled back to neutral during consolidation
  • Trend (ADX) — weaker than I would like to see, but buying pressure (+DI) and selling pressure (-DI) are roughly equal
  • Volume — huge volume on breakout, although tapered off during consolidation

Based on technical analysis, MarketEdge calls ANPI a "strong buy" in a "weak upward trend."

Sell

gain Bottom line
1%

Just a day or so ago, I thought ANPI was starting to move, but it seemed to lose courage in today's sour market, so I decided to sell for a small profit (nearly break-even to put it bluntly), and wait for the market to calm down after earnings.